RxDoctor Payments Data

Siavash Saadat, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Springfield, MANPI 1033406491

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $3,915 of the $6,378 with a category attached, or 61.4%. 8 manufacturers reported payments, led by Atricure, Inc. at 49.5% of the total. Reporting peaked in 2019 at $2,006 and has fallen 65.8% since, to $687 in 2025.

$6,378in general payments, 2019–2025

Across 49 payments — averaging $130.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Atricure, Inc.$3K
  • Edwards Lifesciences$1K
  • Medtronic$1K
  • AstraZeneca$417
  • Artivion, Inc.$115
  • Abbott$109
  • plus $80 from 2 others
$165,314in research payments, 2019–2025

Across 15 payments — averaging $11,021 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$106K
  • AstraZeneca$60K

What the payments were for

  • Travel & lodging$3,91561%
  • Food & beverage$2,46339%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Atricure, Inc.11$3,157
Edwards Lifesciences8$1,384
Medtronic(2 entities)19$1,117
AstraZeneca6$417
Artivion, Inc.1$115
Abbott2$109
Genentech, Inc.1$42
Abiomed1$38

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,378 in reported general payments places this provider in the 55th percentile of 171 thoracic surgery (cardiothoracic vascular surgery) providers in Massachusetts.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Massachusetts

Medicare billing

Part B allowed, 2024
$286,344
Medicare patients
326
Services billed
615

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Springfield

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →